Search

everythinglearnresearchcommunity

for

Search:↓

About 61% of women who had COVID-19 experienced hair loss afterward.

The COVID-19 pandemic caused a drop in phototherapy for skin conditions, with only 40% of vitiligo and psoriasis patients returning after a hospital closure in Taiwan.

During the COVID-19 pandemic in China, skin conditions like eczema and warts increased among children, while respiratory-transmitted skin infections decreased, partly due to mask-wearing.

The combination tablet of finasteride and doxazosin works the same as taking each drug separately.

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

The COVID-19 pandemic increased some stress-related skin diseases but didn't affect others.

The document's conclusion cannot be provided because the content is not available for analysis.

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

The COVID-19 pandemic affected hair restoration practices in 2022.

Teledermatology effectively managed most skin conditions remotely during the COVID-19 pandemic.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

A woman experienced sudden hair graying and loss after a COVID-19 vaccine, which improved with treatment.

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.

A person with a new mutation in the SCN1A gene developed brain inflammation after COVID-19.

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Some COVID-19 patients in Saudi Arabia had skin symptoms, with rashes being the most common.

Six months after COVID-19, most patients still had autoantibodies.

Topical Minoxidil is effective for hair loss after COVID-19.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

A team of different healthcare experts is good for treating long-term COVID-19 issues.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.